Division of Histology and Embryology, International Joint Laboratory for Embryonic Development and Prenatal Medicine, Medical College, Jinan University, Guangzhou, China.
Center for Reproductive Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
J Assist Reprod Genet. 2022 Oct;39(10):2215-2225. doi: 10.1007/s10815-022-02596-9. Epub 2022 Aug 26.
To depict the lncRNA expression during human oocyte maturation and explore the lncRNAs leading to recurrent oocyte maturation arrest.
LncRNA sequencing was performed on pooled RNA from 20 oocytes of each group (recurrent oocyte maturation arrest (ROMA), of germinal vesicle (GV), metaphase I (MI), or metaphase II (MII) stages. Bioinformatics software was deployed to compare the lncRNA differential expression between the normal and ROMA oocytes. The co-expression of lncRNA/mRNA was illustrated with the Cytoscape software. The pooled RNA from every 10 oocytes of each group (ROMA, GV, MI, MII) was extracted for further qPCR validation.
There were 17 downregulated and 3 upregulated lncRNAs in the ROMA oocyte. Among them, co-expression analysis indicated that NEAT1 and NORAD were both downregulated. Basing on the KEGG enrichment analysis, PRCKA and JAK3 might be the target genes in the PI3K-Akt pathway and modulated by NEAT1 and NORAD. As validated by qPCR, the expressional levels of lncRNA candidates (NEAT1 and NORAD) and their target genes (PRKCA and JAK3) were confirmed to be extremely lower in the ROMA oocyte than in the normal oocyte.
By targeting the PI3K-Akt pathway genes PRKCA and JAK3, the abnormal expression of NEAT1 and NORAD is suggested to impede oocyte maturation and impair oocyte genome integrity.
描绘人类卵母细胞成熟过程中的 lncRNA 表达情况,并探讨导致卵母细胞成熟阻滞复发的 lncRNAs。
对 20 个处于正常减数分裂各期(GV 期、MI 期和 MII 期)的卵母细胞的混合 RNA 进行 lncRNA 测序,对正常卵母细胞和 ROMA 卵母细胞进行 lncRNA 差异表达比较。采用 Cytoscape 软件对 lncRNA/mRNA 的共表达进行分析。对每组(ROM、GV、MI、MII)的每 10 个卵母细胞的混合 RNA 进行提取,用于进一步的 qPCR 验证。
ROM 卵母细胞中存在 17 个下调和 3 个上调的 lncRNA。其中,共表达分析表明 NEAT1 和 NORAD 均下调。基于 KEGG 富集分析,PRCKA 和 JAK3 可能是 PI3K-Akt 通路中的靶基因,并受 NEAT1 和 NORAD 调控。qPCR 验证结果表明,候选 lncRNA(NEAT1 和 NORAD)及其靶基因(PRKCA 和 JAK3)在 ROMA 卵母细胞中的表达水平明显低于正常卵母细胞。
通过靶向 PI3K-Akt 通路基因 PRKCA 和 JAK3,提示 NEAT1 和 NORAD 的异常表达可能阻碍卵母细胞成熟并损害卵母细胞基因组完整性。